"The U.S. Food and Drug Administration today approved a new use for Jakafi (ruxolitinib) to treat patients with polycythemia vera, a chronic type of bone marrow disease. Jakafi is the first drug approved by the FDA for this condition.
Agrylin Patient Information including If I Miss a Dose
In this Article
- What is anagrelide (Agrylin)?
- What are the possible side effects of anagrelide (Agrylin)?
- What is the most important information I should know about anagrelide (Agrylin)?
- What should I discuss with my healthcare provider before taking anagrelide (Agrylin)?
- How should I take anagrelide (Agrylin)?
- What happens if I miss a dose (Agrylin)?
- What happens if I overdose (Agrylin)?
- What should I avoid while taking anagrelide (Agrylin)?
- What other drugs will affect anagrelide (Agrylin)?
- Where can I get more information?
What happens if I miss a dose (Agrylin)?
Take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.
What happens if I overdose (Agrylin)?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
Overdose can cause vomiting, or fast heart rate.
What should I avoid while taking anagrelide (Agrylin)?
Do not take aspirin unless your doctor has told you to. Follow your doctor's instructions about how much aspirin to take, and how often to take it.
Ask a doctor or pharmacist before using any other pain, cold, allergy, or sleep medication. Aspirin (sometimes abbreviated as ASA) is contained in many combination medicines. Although aspirin is sometimes prescribed for use with anagrelide, taking these medications together may increase your risk of bleeding. Check the label to see if a medicine contains aspirin or ASA.
Grapefruit and grapefruit juice may interact with anagrelide and lead to potentially dangerous effects. Discuss the use of grapefruit products with your doctor. Do not increase or decrease the amount of grapefruit products in your diet without first talking to your doctor.
What other drugs will affect anagrelide (Agrylin)?
Tell your doctor about all other medicines you use, especially:
- dasatinib (Sprycel);
- deferasirox (Exjade);
- fluvoxamine (Luvox);
- theophylline (Elixophyllin, Theo-24, Uniphyl);
- tipranavir (Aptivus);
- tizanidine (Zanaflex);
- drugs to treat non-Hodgkin's lymphoma, such as ibritumomab (Zevalin), or iodine I-131 tositumomab (Bexxar);
- medication to treat congestive heart failure, such as amrinone (inamrinone, Inocor), enoximone (Perfan), or milrinone (Primacor);
- medicines to treat or prevent blood clots, such as dalteparin (Fragmin), enoxaparin (Lovenox), fondaparinux (Arixtra), or tinzaparin (Innohep); or
- other anti-platelet drugs such as abciximab (ReoPro), cilostazol (Pletal), danaparoid (Orgaran), eptifibatide (Integrelin), prasugrel (Effient), rivaroxaban (Xarelto), or tirofiban (Aggrastat).
This list is not complete and other drugs may interact with anagrelide. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
Where can I get more information?
Your pharmacist can provide more information about anagrelide.
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use this medication only for the indication prescribed.
Every effort has been made to ensure that the information provided by Cerner Multum, Inc. ('Multum') is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Multum information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Multum does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Multum's drug information does not endorse drugs, diagnose patients or recommend therapy. Multum's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Multum does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 1996-2013 Cerner Multum, Inc. Version: 4.02. Revision date: 2/13/2012.
Your use of the content provided in this service indicates that you have read,understood and agree to the End-User License Agreement,which can be accessed by clicking on this link.
Additional Agrylin Information
- Agrylin Drug Interactions Center: anagrelide oral
- Agrylin Side Effects Center
- Agrylin Overview including Precautions
- Agrylin FDA Approved Prescribing Information including Dosage
Agrylin - User Reviews
Agrylin User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.